D7W
1-(3-chlorophenyl)-3-(3-methyl-5-oxidanylidene-4~{H}-imidazol-2-yl)urea
Find entries where: D7W
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
|---|---|
| Name | 1-(3-chlorophenyl)-3-(3-methyl-5-oxidanylidene-4~{H}-imidazol-2-yl)urea |
| Identifiers | 1-(3-chlorophenyl)-3-(3-methyl-5-oxidanylidene-4~{H}-imidazol-2-yl)urea |
| Formula | C11 H11 Cl N4 O2 |
| Molecular Weight | 266.684 |
| Type | NON-POLYMER |
| Isomeric SMILES | CN1CC(=O)N=C1NC(=O)Nc2cccc(c2)Cl |
| InChI | InChI=1S/C11H11ClN4O2/c1-16-6-9(17)14-10(16)15-11(18)13-8-4-2-3-7(12)5-8/h2-5H,6H2,1H3,(H2,13,14,15,17,18) |
| InChIKey | DWPQODZAOSWNHB-UHFFFAOYSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 29 |
| Chiral Atom Count | 0 |
| Bond Count | 30 |
| Aromatic Bond Count | 6 |
Drug Info: DrugBank
| DrugBank ID | DB12931 |
|---|---|
| Name | Fenobam |
| Groups | investigational |
| Description | Fenobam is under investigation in clinical trial NCT00637221 (Open Label Study Investigating Safety and Efficacy of Fenobam anhydrous 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome). |
| Synonyms |
|
| CAS number | 57653-26-6 |
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL239800 |
| PubChem | 162834, 135413554, 135497698, 135659063 |
| ChEMBL | CHEMBL239800 |
| ChEBI | CHEBI:92728 |
